Lifecore Biomedical
LFCR
LFCR
89 hedge funds and large institutions have $306M invested in Lifecore Biomedical in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 90 → 89 (-1)
17% less capital invested
Capital invested by funds: $367M → $306M (-$60.6M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $11K
Holders
89
Holding in Top 10
1
Calls
–
Puts
$11K
Top Buyers
| 1 | +$2.5M | |
| 2 | +$1.66M | |
| 3 | +$1.06M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$810K |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$556K |
Top Sellers
| 1 | -$1.35M | |
| 2 | -$1.28M | |
| 3 | -$1.2M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.19M |
| 5 |
WC
Walthausen & Co
Malta,
New York
|
-$846K |